Miami, FL, United States of America

Nery Ortiz


 

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2003-2023

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Nery Ortiz: Innovator in Hematology Technology

Introduction

Nery Ortiz is a prominent inventor based in Miami, FL, known for his significant contributions to the field of hematology. With a total of 14 patents to his name, Ortiz has developed innovative technologies that enhance the operation and efficiency of hematology analyzers.

Latest Patents

Among his latest patents, Ortiz has introduced methods for operating hematology analyzers. These methods involve passing a control material through the analyzer, which includes distinct cell populations. The process entails measuring the volume of these cell populations and calculating their distribution widths. By comparing these values to established reference ranges, the operational status of the analyzer can be classified effectively. Additionally, Ortiz has developed environmentally-friendly, aqueous concentrated reagent compositions for hematology systems. These reagents are designed for dilution and use in hematology analyzers, facilitating the analysis of blood cells, including enumeration, sizing, and differentiation of leukocyte subpopulations.

Career Highlights

Throughout his career, Nery Ortiz has worked with notable companies such as Beckman Coulter, Inc. and Coulter International Corporation. His experience in these organizations has allowed him to refine his expertise in hematology technology and contribute to advancements in the field.

Collaborations

Ortiz has collaborated with esteemed colleagues, including Theodore J. Gerula and Yi Li, further enhancing the impact of his work in hematology.

Conclusion

Nery Ortiz stands out as an influential inventor in the hematology sector, with a strong portfolio of patents that reflect his commitment to innovation and excellence. His work continues to shape the future of hematology technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…